Nanoviricides (NNVC) Research & Development (2010 - 2026)

Nanoviricides has disclosed Research & Development across 17 years of filings, most recently posting $1.3 million for Q1 2026.

• In Q1 2026, Research & Development changed 0.29% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $4.6 million (down 17.62% YoY), while the FY2025 annual figure was $5.5 million, up 2.06% from the prior year.
• Research & Development came in at $1.3 million for Q1 2026 at Nanoviricides, up from $1.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $2.9 million in Q2 2023 to a low of $993066.0 in Q3 2025.
• Average Research & Development over 5 years is $1.4 million, with a median of $1.2 million recorded in 2023.
• Year-over-year, Research & Development soared 148.64% in 2023 and sank 59.42% in 2024.
• Over 5 years, Research & Development stood at $1.2 million in 2022, then jumped by 34.44% to $1.6 million in 2023, then retreated by 26.53% to $1.2 million in 2024, then decreased by 3.26% to $1.1 million in 2025, then grew by 14.95% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $1.3 million in Q1 2026, $1.1 million in Q4 2025, and $993066.0 in Q3 2025.